Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Dynamiker Biotechnology (Tianjin) Co PEG Ratio?
Dynamiker Biotechnology (Tianjin) CoBJSE:920009 46 PEG Ratio is 4.78 as of Aug. 19, 2026, which is 20% below its 10-year median of 6.00. GuruFocus rates BJSE:920009 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 346 Drug Manufacturers companies, Dynamiker Biotechnology (Tianjin) Co ranks worse than 78.9% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Dynamiker Biotechnology (Tianjin) Co PEG Ratio Related Terms
Dynamiker Biotechnology (Tianjin) Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dynamiker Biotechnology (Tianjin) Co PEG Ratio Chart
BJSE:920009 vs LLY, JNJ, ABBV: PEG Ratio Comparison
For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dynamiker Biotechnology (Tianjin) Co PEG Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a PEG Ratio of 4.78 as of Aug. 19, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. This is 20% below median its historical median of 6.00. Over the past decade, Dynamiker Biotechnology (Tianjin) Co's PEG Ratio has ranged from 4.78 to 6.36. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #273 out of 346 companies in the Drug Manufacturers industry, placing it in the top 78.9%.
Is Dynamiker Biotechnology (Tianjin) Co's PEG Ratio too high?
Dynamiker Biotechnology (Tianjin) Co's current PEG Ratio of 4.78 is 20% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.78 to a high of 6.36. The Drug Manufacturers industry median PEG Ratio is 1.77. Dynamiker Biotechnology (Tianjin) Co's value of 4.78 is 170.8% above this industry median. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #273 out of 346 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's PEG Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #273 out of 346 companies for PEG Ratio. This places Dynamiker Biotechnology (Tianjin) Co in the lower half of its industry. The industry median PEG Ratio is 1.77. Dynamiker Biotechnology (Tianjin) Co's value of 4.78 is 170.8% above this benchmark. Historically, Dynamiker Biotechnology (Tianjin) Co's own PEG Ratio has ranged from 4.78 to 6.36 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 1.77, Dynamiker Biotechnology (Tianjin) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.77, based on 346 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamiker Biotechnology (Tianjin) Co's current PEG Ratio of 4.78 is 170.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current PEG Ratio is 4.78, which is 20% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current PEG Ratio of 4.78. The current PEG Ratio is 4.78, which is 20% below median its 10-year median of 6.00 and 170.8% above the Drug Manufacturers industry median of 1.77. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current PEG Ratio is 4.78 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score
Get the complete analysis for BJSE:920009
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920009 has been successfully added to your 
